Each program will rely on partnerships between Novartis teams and local networks—including health authorities, community organizations and private sector groups
Surgeon Yuvaraja operates on a 55-year-old patient at Medical City Hospital Muscat
The collaboration promises expanded funding for Thai universities, research institutes, companies, and global research partners working in Thailand
Analysis of over 93 lakh preventive health checkups reveals disease risks emerging as early as the 20s
A key milestone in this journey has been the introduction of TREAT Program, a first-of-its-kind clinical initiative introduced in India
The new assay consolidates screening for four major viral threats into a single workflow
The patent protects antiviral compounds developed by the company that inhibit Vacuolar ATPase (V-ATPase) activity in cells, a mechanism involved in viral infection pathways
Vapendavir is an oral, potent, broad-spectrum antiviral active against rhinoviruses and related respiratory enteroviruses
Subscribe To Our Newsletter & Stay Updated
